NeuBase Therapeutics, Inc.
Pharmaceutical company · Pittsburgh, Pennsylvania, United States
NeuBase Therapeutics, Inc. is a pharmaceutical company headquartered in Pittsburgh, Pennsylvania, United States. It has reported private securities offerings to the US SEC, most recently $5 million sold in a notice filed in 2023.
Profile compiled from public records. Is this your company? Request a correction or update
NeuBase Therapeutics at a glance
Typepharmaceutical company
HeadquartersPittsburgh, Pennsylvania, United States
SEC industryPharmaceutical Preparations
SEC CIK1173281
What does NeuBase Therapeutics do?
Private fundraising reported to the SEC
7 Form D notices; the most recent reported $5 million sold (2023).
Frequently asked questions about NeuBase Therapeutics
Where is NeuBase Therapeutics headquartered?
NeuBase Therapeutics, Inc. is headquartered in Pittsburgh, Pennsylvania, United States.
What does NeuBase Therapeutics do?
NeuBase Therapeutics, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Similar companies
- Lipella Pharmaceuticals Inc.Pittsburgh, Pennsylvania, United States
- Duo Oncology Inc.Pittsburgh, Pennsylvania, United States
- Thar Pharmaceuticals IncPittsburgh, Pennsylvania, United States
- Consegna Pharma Inc.Pittsburgh, Pennsylvania, United States
- Creegh Pharmaceuticals, Inc.Pittsburgh, Pennsylvania, United States
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences